stringtranslate.com

List of antineoplastic agents

This is a list of antineoplastic agents used to treat cancer.

References

  1. ^ a b c d e f g Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.
  2. ^ a b c Joint Formulary Committee (2013). British National Formulary (BNF) (65 ed.). London, UK: Pharmaceutical Press. ISBN 978-0-85711-084-8.
  3. ^ Brunton LL, Chabner B, Knollmann BC, eds. (2011). Goodman & Gilman's The Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill. ISBN 978-0-07-162442-8.
  4. ^ a b c Alldredge BK, Corelli RL, Ernst ME, Guglielmo BJ, Jacobson PA, Kradjan WA, Williams BR (February 2012). Applied therapeutics: the clinical use of drugs. Koda Kimble and Youngs Applied Therapeutics (10th ed.). Baltimore, MD: Lippincott Williams & Wilkins. ISBN 978-1-60913-713-7.
  5. ^ Sweetman, S (ed.). Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 8 February 2014.
  6. ^ Martens, UM, ed. (2010). "11 5-Azacytidine/Azacitidine". Small molecules in oncology. Recent Results in Cancer Research. Vol. 184. Heidelberg: Springer. pp. 159–170. doi:10.1007/978-3-642-01222-8. ISBN 978-3-642-01222-8.
  7. ^ Spurgeon, Stephen; Yu, Margaret; Phillips, John D.; Epner, Elliot M. (2009-08-01). "Cladribine: not just another purine analogue?". Expert Opinion on Investigational Drugs. 18 (8): 1169–1181. doi:10.1517/13543780903071038. ISSN 1354-3784. PMID 19604118. S2CID 22355364.
  8. ^ Bryson, Harriet M.; Sorkin, Eugene M. (1993-11-01). "Cladribine". Drugs. 46 (5): 872–894. doi:10.2165/00003495-199346050-00007. ISSN 0012-6667. PMID 7507037.
  9. ^ Robak, Tadeusz; Korycka, Anna; Robak, Ewa (2005-12-31). "Older and New Formulations of Cladribine. Pharmacology and Clinical Efficacy in Hematological Malignancies". Recent Patents on Anti-Cancer Drug Discovery. 1 (1): 23–38. doi:10.2174/157489206775246467. PMID 18221024.
  10. ^ Hentosh, Patricia; Peffley, Dennis M. (2010-01-01). "The cladribine conundrum: deciphering the drug's mechanism of action". Expert Opinion on Drug Metabolism & Toxicology. 6 (1): 75–81. doi:10.1517/17425250903393745. ISSN 1742-5255. PMID 19968576. S2CID 41433204.
  11. ^ Ghanem H, Kantarjian H, Ohanian M, Jabbour E (Apr 2013). "The role of clofarabine in acute myeloid leukemia". Leukemia & Lymphoma. 54 (4): 688–698. doi:10.3109/10428194.2012.726722. PMC 5681218. PMID 22957815.
  12. ^ Timmer, Antje; Patton, Petrease H.; Chande, Nilesh; McDonald, John W. D.; MacDonald, John K. (2016-05-18). "Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis". The Cochrane Database of Systematic Reviews. 2016 (5): CD000478. doi:10.1002/14651858.CD000478.pub4. ISSN 1469-493X. PMC 7034525. PMID 27192092.
  13. ^ "Arranon (nelarabine) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 11 February 2014.
  14. ^ "Pralatrexate", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31643237, retrieved 2024-04-11
  15. ^ "Trimetrexate", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31644074, retrieved 2024-04-11
  16. ^ a b c d e f g h i Bhatia, S (2008). "Secondary Malignancies: Therapy-Related t-MDS/AML". Medscape Reference. WebMD. Retrieved 7 February 2014.
  17. ^ "Lurbinectedin", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 36576980, retrieved 2024-04-10
  18. ^ "Mechlorethamine", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31643828, retrieved 2024-04-10
  19. ^ "Thiotepa", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31643502, retrieved 2024-04-11
  20. ^ "Trabectedin", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID 31643478, retrieved 2024-04-11
  21. ^ "Vandetanib dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 9 February 2014.
  22. ^ "Targretin (bexarotene) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 9 February 2014.
  23. ^ Matthay KK (Jan 2013). "Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption". Clinical Cancer Research. 19 (2): 311–313. doi:10.1158/1078-0432.CCR-12-3313. PMC 5892183. PMID 23209029.
  24. ^ "Amnesteem, Claravis (isotretinoin) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 9 February 2014.
  25. ^ "Isotretinoin 20mg capsules – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Alliance Pharmaceuticals. 12 April 2013. Retrieved 9 February 2014.